Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.9M Buy
60,423
+1,241
+2% +$425K 1.61% 20
2026
Q1
$20.8M Buy
59,182
+522
+0.9% +$186K 1.75% 20
2025
Q4
$19.2M Sell
58,660
-1
-0% -$317 1.58% 19
2025
Q3
$16.6M Buy
58,661
+5,839
+11% +$1.69M 1.4% 30
2025
Q2
$14.7M Buy
52,822
+10,666
+25% +$3.02M 1.4% 31
2025
Q1
$13.1M Sell
42,156
-635
-1% -$188K 1.65% 23
2024
Q4
$11.2M Buy
42,791
+2,274
+6% +$675K 1.33% 32
2024
Q3
$13.1M Buy
40,517
+1,645
+4% +$538K 1.59% 23
2024
Q2
$12.1M Sell
38,872
-72
-0.2% -$21.2K 1.57% 24
2024
Q1
$11.1M Buy
38,944
+440
+1% +$129K 1.48% 26
2023
Q4
$11.1M Buy
38,504
+1,691
+5% +$461K 1.67% 20
2023
Q3
$9.89M Sell
36,813
-92
-0.2% -$23K 1.72% 18
2023
Q2
$8.19M Buy
36,905
+393
+1% +$91.2K 1.39% 28
2023
Q1
$8.83M Buy
36,512
+682
+2% +$167K 1.64% 23
2022
Q4
$9.41M Buy
+35,830
New +$9.6M 1.94% 18

Other funds holding AMGN

Talbot Financial's AMGN Position: Q2 2026 in Review

Talbot Financial increased its Amgen (AMGN) stake by 2.1% in Q2 2026, buying an estimated $425K and bringing the position to 60,423 shares worth $21.9M. The position accounts for 1.61% of the portfolio, ranked #20.

Talbot Financial first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Talbot Financial held 60,423 shares of Amgen worth $21.9M as of Q2 2026.
  • Talbot Financial bought 1,241 Amgen shares in Q2 2026, an estimated $425K.
  • Amgen made up 1.61% of Talbot Financial's portfolio in Q2 2026, its #20 holding.
  • Talbot Financial first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Talbot Financial's 13F filing for Q2 2026, filed 14 Jul 2026.